If calculated more strictly according to cosmetic standards, the number of people with ptosis may double. Approximately 30,000 to 40,000 newborns are born with congenital ptosis every year.

In the past, ophthalmology focused on treating ptosis. The main purpose of treatment at that time was to prevent children from having their vision affected by upper eyelid occlusion. In order to allow children to see relatively normally, "frontalis muscle flap suspension" and "levator aponeurosis shortening" were commonly used in the past to correct ptosis.

The effect of this corrective treatment is that the upper eyelids reduce the obstruction of the cornea, which relatively improves the ability to see things normally. However, this method is difficult to last, and most cases occur within three months or half a year after the operation. It will recur internally, and it cannot take into account the appearance. The muscle removal and tissue damage are also irreversible.

The two surgeries, "frontalis muscle flap suspension" and "levator aponeurosis shortening", have positive and correct concepts in disease treatment. They once corrected ptosis in children. Symptoms, and its "visual function" can be exercised to a certain extent in the early stage. In the process of medical development, it has made a historic contribution in the field of ptosis.

However, the medical process is constantly developing, and the surgical methods for treating diseases are also constantly improving and improving. Based on the previous ones, President Wang Zhenjun hopes to have a better treatment effect. Opening the eyes also improves the aesthetics of the eyes, and reduces complications and adverse consequences.

Through long-term research and promotion of the use of CFS sling surgery to treat ptosis, the combination of fascia sheath treatment for ptosis has achieved good results in terms of therapeutic effect, cosmetic degree and complications. clinical effects and widespread recognition.